SANA
SANA
NASDAQ · Biotechnology

Sana Biotechnology Inc

$2.56
+0.12 (+4.92%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +1,465.6% upside
Low Target $23.55
Average Target $40.08
High Target $57.48
Current Price $2.56
Current
$2.56
Target
$40.08
$23.55 $40.08 avg $57.48
Scenario Analysis
Bear Case
$23.55
819.9%
Low target
Base Case
$40.08
+1,465.6%
Avg target
Bull Case
$57.48
+2,145.3%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$5.58
-54.1% from high
52-Week Low
$2.22
+15.3% from low
Target vs 52W High
$40.08
+618.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -35.8%